The Implication of NT-proBNP in the Assessment of the Clinical Phenotype of Patients with Type 2 Diabetes Mellitus, Without Established Cardiovascular Disease

Ioannis Gastouniotis(National and Kapodistrian University of Athens), Konstantinos Tsioufis(National and Kapodistrian University of Athens), Anastasia Thanopoulou(National and Kapodistrian University of Athens), Alexandrina Kouroutzoglou(Hippocration General Hospital), Christina Chrysohoou(National and Kapodistrian University of Athens), Alexios S. Antonopoulos(National and Kapodistrian University of Athens), Marina Noutsou(National and Kapodistrian University of Athens), Christos Fragoulis(National and Kapodistrian University of Athens)
Biomedicines
November 27, 2024
10.3390/biomedicines12122718
Cited by 4

Related Papers

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data
|The Lancet|2018|1.1k
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
|The Lancet|2018|781
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
|The Lancet|2017|739
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
|The Lancet|2020|593